过去一年中添加的文章,按日期排序
Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic Pathways
A Pellerin, Y Tan, S Lu, RG Bonegio… - The Journal of …, 2023 - journals.aai.org
279 天前 - … and an impaired ability of myeloid cells in the kidney to produce inflammatory
cytokines. Overall, our findings support consideration of IRF5 as a therapeutic target in SLE. …
cytokines. Overall, our findings support consideration of IRF5 as a therapeutic target in SLE. …
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T
279 天前 - … The elevated levels of these cytokines in serum of SLE patients were found to
correlate … Targeting of cytokines is one more approach in addition to above-mentioned of SLE …
correlate … Targeting of cytokines is one more approach in addition to above-mentioned of SLE …
The Emerging Role of Chimeric Antigen Receptor Therapies in the Treatment of Autoimmune Disorders
S Bloodworth - jmsgr.tamhsc.edu
280 天前 - … identifiable off-target toxicity or related cytokine storm. Lee, … systemic lupus
erythematosus achieved complete remission after receiving the currently approved CART19 therapy…
erythematosus achieved complete remission after receiving the currently approved CART19 therapy…
Autoimmune responses and therapeutic interventions for systemic lupus erythematosus: a comprehensive review
282 天前 - … hormones trigger the onset of SLE pathogenesis in genetically susceptible individuals
… cytokines, macrophages, T cells, and B cells. Diagnosis and clinical investigations of SLE …
… cytokines, macrophages, T cells, and B cells. Diagnosis and clinical investigations of SLE …
Immune podocytes in the immune microenvironment of lupus nephritis
R Liu, X Wen, X Peng, M Zhao… - Molecular Medicine …, 2023 - spandidos-publications.com
283 天前 - … evaluates podocytes as a potential therapeutic target for LN. … Systemic lupus
erythematosus (SLE) is a chronic … anti-nucleosome antibodies) and cytokines they produce. T cells …
erythematosus (SLE) is a chronic … anti-nucleosome antibodies) and cytokines they produce. T cells …
[HTML][HTML] Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
KH Chun, YC Park, N Hwang, BK Yoon, J Kim… - Scientific Reports, 2023 - nature.com
285 天前 - … of skin immune cells in systemic lupus erythematosus (SLE), atopic dermatitis (AD),
and … SLE, AD, and PS, confirming that dendritic cells produce pro-inflammatory cytokines to …
and … SLE, AD, and PS, confirming that dendritic cells produce pro-inflammatory cytokines to …
[HTML][HTML] HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
W Ren, L Zhao, Y Sun, X Wang, X Shi - Molecular Medicine, 2023 - Springer
292 天前 - … cytokines and eliciting inflammatory responses. The potential of HMGB1 and TLRs
as therapeutic targets … Systemic lupus erythematosus (SLE), an autoimmune disease closely …
as therapeutic targets … Systemic lupus erythematosus (SLE), an autoimmune disease closely …
Molecular consideration relevant to the mechanism of the comorbidity between psoriasis and systemic lupus erythematosus
Y Qu, D Li, W Liu, D Shi - … and Therapeutic Medicine, 2023 - spandidos-publications.com
299 天前 - … cytokines with effector Th17 cells, T regulatory cells, as well as B cells. In addition,
the therapeutic … , and has also become evident in SLE. However, the mechanisms have not …
the therapeutic … , and has also become evident in SLE. However, the mechanisms have not …
31 Other targets: expectations from research on pathogenic mechanisms
T Dörner - 2023 - lupus.bmj.com
300 天前 - … as other proinflammatory cytokines and … in SLE may be identified as targets for
treatment, use of bispecific antibodies12 may hold promise to improve selective immune therapy …
treatment, use of bispecific antibodies12 may hold promise to improve selective immune therapy …
MiR-21 Regulation of Systemic Autoimmunity and Immunity
K Bricker - 2023 - etda.libraries.psu.edu
302 天前 - … Abstract: Systemic lupus erythematosus (SLE) is a … its potential as a therapeutic
target. Principle investigations of … cells produced less inflammatory cytokines and had reduced …
target. Principle investigations of … cells produced less inflammatory cytokines and had reduced …